1 METHODOLOGY
1.1 OUR APPROACH

2 THE WORLD MARKET
2.1 EXPORTS
2.1.1 THE WORLD MARKET: VACCINES, ANTISERA, AND OTHER BLOOD FRACTIONS EXPORT SUPPLIES IN 2022
2.2 IMPORTS
2.2.1 THE WORLD MARKET: IMPORTED VACCINES, ANTISERA, AND OTHER BLOOD FRACTIONS IN 2022

3 EXPORTS
3.1 AFRICA: EXPORT SUPPLIES OF VACCINES, ANTISERA, AND OTHER BLOOD FRACTIONS IN 2022
3.1.1 EXECUTIVE SUMMARY
3.1.2 BOTSWANA
3.1.3 CAMEROON
3.1.4 EGYPT
3.1.5 ESWATINI
3.1.6 ETHIOPIA
3.1.7 KENYA
3.1.8 MALI
3.1.9 MAURITIUS
3.1.10 MOROCCO
3.1.11 NAMIBIA
3.1.12 NIGERIA
3.1.13 RWANDA
3.1.14 SENEGAL
3.1.15 SOUTH AFRICA
3.1.16 TANZANIA
3.1.17 THE CENTRAL AFRICAN REPUBLIC
3.1.18 TUNISIA
3.1.19 UGANDA
3.1.20 ZIMBABWE
3.2 ASIA: EXPORT SUPPLIES OF VACCINES, ANTISERA, AND OTHER BLOOD FRACTIONS IN 2022
3.2.1 EXECUTIVE SUMMARY
3.2.2 BANGLADESH
3.2.3 CHINA
3.2.4 HONG KONG
3.2.5 INDIA
3.2.6 INDONESIA
3.2.7 JAPAN
3.2.8 MALAYSIA
3.2.9 NEPAL
3.2.10 NORTH KOREA
3.2.11 SINGAPORE
3.2.12 SOUTH KOREA
3.2.13 SRI LANKA
3.2.14 TAIWAN
3.2.15 THAILAND
3.2.16 THE PHILIPPINES
3.2.17 VIETNAM
3.3 EUROPE: EXPORT SUPPLIES OF VACCINES, ANTISERA, AND OTHER BLOOD FRACTIONS IN 2022
3.3.1 EXECUTIVE SUMMARY
3.3.2 AUSTRIA
3.3.3 BELARUS
3.3.4 BELGIUM
3.3.5 BOSNIA AND HERZEGOVINA
3.3.6 BULGARIA
3.3.7 CROATIA
3.3.8 CYPRUS
3.3.9 DENMARK
3.3.10 ESTONIA
3.3.11 FINLAND
3.3.12 FRANCE
3.3.13 GEORGIA
3.3.14 GERMANY
3.3.15 GREECE
3.3.16 HUNGARY
3.3.17 ICELAND
3.3.18 IRELAND
3.3.19 ITALY
3.3.20 KAZAKHSTAN
3.3.21 LATVIA
3.3.22 LITHUANIA
3.3.23 LUXEMBOURG
3.3.24 MACEDONIA
3.3.25 MALTA
3.3.26 NORWAY
3.3.27 POLAND
3.3.28 PORTUGAL
3.3.29 ROMANIA
3.3.30 RUSSIA
3.3.31 SLOVAKIA
3.3.32 SLOVENIA
3.3.33 SPAIN
3.3.34 SWEDEN
3.3.35 SWITZERLAND
3.3.36 THE CZECH REPUBLIC
3.3.37 THE NETHERLANDS
3.3.38 THE UNITED KINGDOM
3.3.39 UKRAINE
3.4 LATIN AMERICA: EXPORT SUPPLIES OF VACCINES, ANTISERA, AND OTHER BLOOD FRACTIONS IN 2022
3.4.1 EXECUTIVE SUMMARY
3.4.2 ARGENTINA
3.4.3 BRAZIL
3.4.4 CHILE
3.4.5 COLOMBIA
3.4.6 COSTA RICA
3.4.7 ECUADOR
3.4.8 EL SALVADOR
3.4.9 GUATEMALA
3.4.10 HONDURAS
3.4.11 MEXICO
3.4.12 NICARAGUA
3.4.13 PANAMA
3.4.14 PARAGUAY
3.4.15 PERU
3.4.16 URUGUAY
3.4.17 VENEZUELA
3.5 NORTH AMERICA & THE CARIBBEAN: EXPORT SUPPLIES OF VACCINES, ANTISERA, AND OTHER BLOOD FRACTIONS IN 2022
3.5.1 EXECUTIVE SUMMARY
3.5.2 BERMUDA
3.5.3 CANADA
3.5.4 CUBA
3.5.5 ST. KITTS AND NEVIS
3.5.6 THE DOMINICAN REPUBLIC
3.5.7 THE UNITED STATES
3.6 OCEANIA: EXPORT SUPPLIES OF VACCINES, ANTISERA, AND OTHER BLOOD FRACTIONS IN 2022
3.6.1 EXECUTIVE SUMMARY
3.6.2 AUSTRALIA
3.6.3 NEW ZEALAND
3.7 THE MIDDLE EAST: EXPORT SUPPLIES OF VACCINES, ANTISERA, AND OTHER BLOOD FRACTIONS IN 2022
3.7.1 EXECUTIVE SUMMARY
3.7.2 AFGHANISTAN
3.7.3 ARMENIA
3.7.4 IRAN
3.7.5 IRAQ
3.7.6 ISRAEL
3.7.7 JORDAN
3.7.8 LEBANON
3.7.9 PAKISTAN
3.7.10 SAUDI ARABIA
3.7.11 SYRIA
3.7.12 THE UNITED ARAB EMIRATES
3.7.13 TURKEY
3.7.14 UZBEKISTAN

4 IMPORTS
4.1 AFRICA: VACCINES, ANTISERA, AND OTHER BLOOD FRACTIONS IMPORTS IN 2022
4.1.1 EXECUTIVE SUMMARY
4.1.2 ALGERIA
4.1.3 BENIN
4.1.4 BOTSWANA
4.1.5 BURKINA FASO
4.1.6 BURUNDI
4.1.7 CAMEROON
4.1.8 CAPE VERDE
4.1.9 COTE D'IVOIRE
4.1.10 EGYPT
4.1.11 ETHIOPIA
4.1.12 GUINEA
4.1.13 MADAGASCAR
4.1.14 MALAWI
4.1.15 MAURITANIA
4.1.16 MAURITIUS
4.1.17 MOROCCO
4.1.18 MOZAMBIQUE
4.1.19 NAMIBIA
4.1.20 NIGER
4.1.21 NIGERIA
4.1.22 RWANDA
4.1.23 SENEGAL
4.1.24 SOUTH AFRICA
4.1.25 TANZANIA
4.1.26 THE CENTRAL AFRICAN REPUBLIC
4.1.27 THE DEMOCRATIC REPUBLIC OF THE CONGO
4.1.28 UGANDA
4.1.29 ZAMBIA
4.1.30 ZIMBABWE
4.2 ASIA: VACCINES, ANTISERA, AND OTHER BLOOD FRACTIONS IMPORTS IN 2022
4.2.1 EXECUTIVE SUMMARY
4.2.2 BRUNEI
4.2.3 CHINA
4.2.4 HONG KONG
4.2.5 INDIA
4.2.6 INDONESIA
4.2.7 JAPAN
4.2.8 MACAU
4.2.9 MALAYSIA
4.2.10 MONGOLIA
4.2.11 NEPAL
4.2.12 SINGAPORE
4.2.13 SOUTH KOREA
4.2.14 SRI LANKA
4.2.15 TAIWAN
4.2.16 THAILAND
4.2.17 THE MALDIVES
4.2.18 THE PHILIPPINES
4.2.19 VIETNAM
4.3 EUROPE: VACCINES, ANTISERA, AND OTHER BLOOD FRACTIONS IMPORTS IN 2022
4.3.1 EXECUTIVE SUMMARY
4.3.2 ALBANIA
4.3.3 ANDORRA
4.3.4 AUSTRIA
4.3.5 BELARUS
4.3.6 BELGIUM
4.3.7 BOSNIA AND HERZEGOVINA
4.3.8 BULGARIA
4.3.9 CROATIA
4.3.10 CYPRUS
4.3.11 DENMARK
4.3.12 ESTONIA
4.3.13 FINLAND
4.3.14 FRANCE
4.3.15 GEORGIA
4.3.16 GERMANY
4.3.17 GREECE
4.3.18 HUNGARY
4.3.19 ICELAND
4.3.20 IRELAND
4.3.21 ITALY
4.3.22 KAZAKHSTAN
4.3.23 LATVIA
4.3.24 LITHUANIA
4.3.25 LUXEMBOURG
4.3.26 MACEDONIA
4.3.27 MALTA
4.3.28 MOLDOVA
4.3.29 NORWAY
4.3.30 POLAND
4.3.31 PORTUGAL
4.3.32 ROMANIA
4.3.33 RUSSIA
4.3.34 SLOVAKIA
4.3.35 SLOVENIA
4.3.36 SPAIN
4.3.37 SWEDEN
4.3.38 SWITZERLAND
4.3.39 THE CZECH REPUBLIC
4.3.40 THE NETHERLANDS
4.3.41 THE UNITED KINGDOM
4.3.42 UKRAINE
4.4 LATIN AMERICA: VACCINES, ANTISERA, AND OTHER BLOOD FRACTIONS IMPORTS IN 2022
4.4.1 EXECUTIVE SUMMARY
4.4.2 ARGENTINA
4.4.3 BELIZE
4.4.4 BOLIVIA
4.4.5 BRAZIL
4.4.6 CHILE
4.4.7 COLOMBIA
4.4.8 ECUADOR
4.4.9 EL SALVADOR
4.4.10 GUATEMALA
4.4.11 GUYANA
4.4.12 HONDURAS
4.4.13 MEXICO
4.4.14 NICARAGUA
4.4.15 PANAMA
4.4.16 PARAGUAY
4.4.17 PERU
4.4.18 SURINAME
4.4.19 URUGUAY
4.5 NORTH AMERICA & THE CARIBBEAN: VACCINES, ANTISERA, AND OTHER BLOOD FRACTIONS IMPORTS IN 2022
4.5.1 EXECUTIVE SUMMARY
4.5.2 ANTIGUA AND BARBUDA
4.5.3 ARUBA
4.5.4 BARBADOS
4.5.5 BERMUDA
4.5.6 CANADA
4.5.7 GREENLAND
4.5.8 JAMAICA
4.5.9 THE BAHAMAS
4.5.10 THE DOMINICAN REPUBLIC
4.5.11 THE UNITED STATES
4.6 OCEANIA: VACCINES, ANTISERA, AND OTHER BLOOD FRACTIONS IMPORTS IN 2022
4.6.1 EXECUTIVE SUMMARY
4.6.2 AUSTRALIA
4.6.3 FIJI
4.6.4 FRENCH POLYNESIA
4.6.5 NEW CALEDONIA
4.6.6 NEW ZEALAND
4.6.7 PALAU
4.6.8 TONGA
4.7 THE MIDDLE EAST: VACCINES, ANTISERA, AND OTHER BLOOD FRACTIONS IMPORTS IN 2022
4.7.1 EXECUTIVE SUMMARY
4.7.2 ARMENIA
4.7.3 AZERBAIJAN
4.7.4 BAHRAIN
4.7.5 ISRAEL
4.7.6 JORDAN
4.7.7 KUWAIT
4.7.8 LEBANON
4.7.9 OMAN
4.7.10 PAKISTAN
4.7.11 QATAR
4.7.12 TURKEY
4.7.13 YEMEN

5 DISCLAIMERS, WARRANTIES, AND USER AGREEMENT PROVISIONS
5.1 DISCLAIMERS & SAFE HARBOR
5.2 ICON GROUP INTERNATIONAL, INC. USER AGREEMENT PROVISIONS